COVID-19: Triple Antiviral Therapy & IL-1 Inhibition
Background: Current management of COVID-19 focuses on supportive care as there are yet to be robust, data driven treatments. To date, there has barely been a glimmer of hope based on published evidence, as most studies are either poor quality ...